Regeneron Pharmaceuticals, Inc. (REGN) Licenses Gibson SOLA Platform to Boost R&D Efficiency

May 30, 2025 - 14:00

0

Regeneron Pharmaceuticals, Inc. (REGN) Licenses Gibson SOLA Platform to Boost R&D Efficiency

Related Posts

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025 4

Dream Finders Homes director Lovett sells $2.65 million in stock

Dream Finders Homes director Lovett sells $2.65 million...

Mar 21, 2025 0

Coty Divests Stake in SKKN by Kim

Coty Divests Stake in SKKN by Kim

Mar 21, 2025 0

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGT

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corp...

Mar 21, 2025 0

Argentina suspends Telecom's purchase of Telefonica unit

Argentina suspends Telecom's purchase of Telefonica unit

Mar 21, 2025 2

ZipRecruiter SVP Bartolome Lora sells $12,861 in shares

ZipRecruiter SVP Bartolome Lora sells $12,861 in shares

Mar 21, 2025 1